About
Dr. MingXi Li serves as Partner at GT Healthcare Capital Partners. Experienced with identifying innovative technologies and commercializing them, MingXi is a US trained professional focusing on life science sector with keen understanding of global and China healthcare market. He has established a track record of investing in China as well as cross-border transactions, and stayed well connected with industrial leaders, entrepreneurs, investors and academia in both China and US. MingXi serves on the board of a number of prominent pharmaceutical and diagnostic companies in China as well. He was Senior Director at Simcere Pharmaceutical Group from 2013 to 2017, and managed Simcere’s portfolio of investments (>150M USD) in various venture funds, including Cormorant Asset Management (MA, USA), Ally Bridge Group (HK), Partners Innovation Fund (MA, USA), PointGuard Ventures (CA, USA), Bohe Angels (Suzhou, China) and Tenyall Capital (Nanjing, China). He also served on the investment committee
Position in the VCSift Database
- • 4 investors at GT Healthcare Capital Partners are tracked.
- • 2,531 investors hold the Partner role in VCSift. Mingxi Li is one of them.
- • 39 investors are based in Jingan, Shanghai, China.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Jingan, China
Contact Information
Find more investors like Mingxi
Search Investors